Suven Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	3,375	150.26	149.32	370.19	52.74
Short-Term Investments	1,844	227.01	1,490	1,451	-
Trading Asset Securities	-	222.79	759.35	463.39	451.62
Cash & Short-Term Investments	5,218	600.05	2,399	2,284	504.36
Cash Growth	769.62%	-74.98%	5.01%	352.91%	8.80%
Accounts Receivable	15.08	13.36	12.86	8.07	12.98
Other Receivables	-	0.76	22.02	47.67	75.25
Receivables	15.08	14.12	34.88	55.74	88.23
Inventory	1.02	2.38	7.08	0.08	0.33
Prepaid Expenses	-	10.02	5.9	3.57	4.33
Other Current Assets	232.88	128.16	120.19	172.19	68.7
Total Current Assets	5,467	754.72	2,567	2,516	665.95
Property, Plant & Equipment	764.47	594.82	280.1	370.16	408.91
Long-Term Investments	8.75	-	-	1,000	-
Other Intangible Assets	1.45	1.81	1.99	1.98	2.25
Other Long-Term Assets	0.39	0.49	0.21	1.1	3.25
Total Assets	6,242	1,352	2,849	3,889	1,080
Accounts Payable	48.13	52.27	20.68	16.65	19.87
Accrued Expenses	93.9	182.59	106.91	82.48	40.19
Current Portion of Long-Term Debt	-	-	-	-	4.84
Current Portion of Leases	166.94	-	7.1	10.26	11.51
Current Unearned Revenue	-	-	-	-	0.56
Other Current Liabilities	-	-	0.47	1.91	6.18
Total Current Liabilities	308.97	234.86	135.16	111.3	83.15
Long-Term Leases	-	-	-	5.79	15.73
Pension & Post-Retirement Benefits	-	-	-	3.77	7.97
Other Long-Term Liabilities	19.17	17.11	13.46	15.05	12.05
Total Liabilities	328.14	251.97	148.62	135.91	118.89
Common Stock	263.72	218.07	218.07	218.07	145.38
Additional Paid-In Capital	-	6,468	6,468	6,468	2,566
Retained Earnings	-	-5,573	-3,965	-2,914	-1,733
Comprehensive Income & Other	5,650	-12.91	-20.42	-18.99	-17.46
Shareholders' Equity	5,914	1,100	2,700	3,753	961.45
Total Liabilities & Equity	6,242	1,352	2,849	3,889	1,080
Total Debt	166.94	-	7.1	16.05	32.09
Net Cash (Debt)	5,051	600.05	2,392	2,268	472.27
Net Cash Growth	741.79%	-74.91%	5.44%	380.28%	13.55%
Net Cash Per Share	22.17	2.75	10.97	12.72	3.50
Filing Date Shares Outstanding	225.72	218.07	218.07	218.07	145.38
Total Common Shares Outstanding	225.72	218.07	218.07	218.07	145.38
Working Capital	5,158	519.86	2,432	2,405	582.8
Book Value Per Share	26.20	5.04	12.38	17.21	6.61
Tangible Book Value	5,913	1,098	2,698	3,751	959.21
Tangible Book Value Per Share	26.19	5.04	12.37	17.20	6.60
Land	-	329.29	3.18	3.18	3.18
Machinery	-	794.82	764.27	860.18	797.35
Construction In Progress	-	0.1	-	-	35.51